Yarrow Bioscience, Inc. - Common Stock (YARW)
Investment Snapshot
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -122.2%
- Revenue growing at 14% annually
Yarrow Bioscience, Inc. - Common Stock (YARW) is a publicly traded company, listed on the NASDAQ . Key value metrics: Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Yarrow Bioscience, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, YARW shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -122.2%.
StockPik's composite Value Score for YARW is 35/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
YARW shows revenue growing at 14% year-over-year, with earnings growing at 34%.